Literature DB >> 12871333

Platelet characteristics associated with coronary artery disease.

R D McBane1, K Karnicki, N Tahirkheli, R S Miller, W G Owen.   

Abstract

BACKGROUND/
OBJECTIVE: To test the hypothesis that circulating platelets display evidence of interactions with atherogenesis, platelet capacity to express P-selectin and propensity for spontaneous microaggregation in vitro were measured in samples from normal donors (N), patients with asymptomatic advanced coronary calcification (CC) or acute coronary syndromes (AC). To measure the effect of angioplasty on platelet function, samples obtained before, 30 min after and 24 h after angioplasty were compared. PATIENTS/
METHODS: Platelet P-selectin was measured after maximal stimulation with thrombin. Microaggregation was measured as a platelet count deficit in citrate-anticoagulated platelet-rich plasma (PRP) relative to EDTA-anticoagulated blood.
RESULTS: P-selectin expression was significantly lower for platelets from patients with either AC or CC compared to normals. In addition, platelets from AC and CC patients have a significantly greater propensity to form microaggregates in citrate anticoagulant. After angioplasty, the PRP-platelet count decreased transiently.
CONCLUSION: Both acute unstable and chronic stable coronary disease are associated with an increased share of platelets unable to express P-selectin and an increased share of platelets that microaggregate in citrate anticoagulant. The genesis of these platelet characteristics is not fully explained by focal acute arterial injury and may reflect exposure to systemic atherosclerosis or the atherogenic process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871333     DOI: 10.1046/j.1538-7836.2003.00183.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  9 in total

1.  Circulating microparticles and endogenous estrogen in newly menopausal women.

Authors:  M Jayachandran; R D Litwiller; W G Owen; V M Miller
Journal:  Climacteric       Date:  2009-04       Impact factor: 3.005

2.  Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study.

Authors:  Meagan O'Brien; Emilie Montenont; Liang Hu; Michael A Nardi; Vanessa Valdes; Michael Merolla; Gabrielle Gettenberg; Karen Cavanagh; Judith A Aberg; Nina Bhardwaj; Jeffrey S Berger
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07-01       Impact factor: 3.731

3.  Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women.

Authors:  Limor Raz; M Jayachandran; Nirubol Tosakulwong; Timothy G Lesnick; Samantha M Wille; Matthew C Murphy; Matthew L Senjem; Jeffrey L Gunter; Prashanthi Vemuri; Clifford R Jack; Virginia M Miller; Kejal Kantarci
Journal:  Neurology       Date:  2013-02-13       Impact factor: 9.910

4.  Platelet response as a sentinel marker of toll-like receptor 4 activation in mice.

Authors:  Muthuvel Jayachandran; Virginia M Miller; Gregory J Brunn; Whyte G Owen
Journal:  Thromb Res       Date:  2009-05-31       Impact factor: 3.944

5.  Propensity for young reticulated platelet recruitment into arterial thrombi.

Authors:  Robert D McBane; Catherine Gonzalez; David O Hodge; Waldemar E Wysokinski
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

6.  Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk.

Authors:  Muthuvel Jayachandran; Robert D Litwiller; Brian D Lahr; Kent R Bailey; Whyte G Owen; Sharon L Mulvagh; John A Heit; Howard N Hodis; S Mitchell Harman; Virginia M Miller
Journal:  J Cardiovasc Transl Res       Date:  2011-07-24       Impact factor: 4.132

7.  Longitudinal effects of menopausal hormone treatments on platelet characteristics and cell-derived microvesicles.

Authors:  Virginia M Miller; Brian D Lahr; Kent R Bailey; John A Heit; S Mitchell Harman; Muthuvel Jayachandran
Journal:  Platelets       Date:  2015-04-09       Impact factor: 3.862

8.  Menopausal hormone therapy, blood thrombogenicity, and development of white matter hyperintensities in women of the Kronos Early Estrogen Prevention Study.

Authors:  Muthuvel Jayachandran; Brian D Lahr; Kent R Bailey; Virginia M Miller; Kejal Kantarci
Journal:  Menopause       Date:  2020-03       Impact factor: 3.310

9.  Platelet and leukocyte activation, atherosclerosis and inflammation in European and South Asian men.

Authors:  O Dotsenko; N Chaturvedi; S A McG Thom; A R Wright; J Mayet; A Shore; C Schalkwijk; A D Hughes
Journal:  J Thromb Haemost       Date:  2007-10       Impact factor: 5.824

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.